Avanafil - VIVUS
Alternative Names: RAZATUS; Spedra; Stendra; TA-1790; ZepeedLatest Information Update: 21 Nov 2022
At a glance
- Originator Tanabe Seiyaku
- Developer Acerus Pharmaceuticals; JW Pharmaceutical; Menarini; Petros Pharmaceuticals; VIVUS
- Class Erectile dysfunction therapies; Pyrimidines; Small molecules
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Erectile dysfunction
Highest Development Phases
- Marketed Erectile dysfunction
- Discontinued Female sexual dysfunction; Premature ejaculation